Production of cardiovascular and antibiotic drugs toped

Published: 2005-07-20 07:00:00

Updated: 2005-07-20 07:00:00

The KFDA reported based on the KPMA data that the cardiovascular drugs were produced far higher value at 1,539,936 million won, the top out of the whole therapeutic categories than the GI therapeutic drugs in 2004, but number of product registration showed more on the GI drugs than the cardiovasc...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK